Gritstone Oncology Inc. announced the appointment of Steve E. Krognes to the company’s board of directors. Mr. Krognes, who currently serves as the chief financial officer of Denali Therapeutics Inc., brings more than 25 years of finance and life sciences industry experience to Gritstone Oncology, including experience in investment banking, corporate and operational finance, mergers and acquisitions and as a board director.